Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus. (Q51473685)
Jump to navigation
Jump to search
scientific article published in March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus. |
scientific article published in March 2007 |
Statements
1 reference
Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus. (English)
1 reference
Valmore J Bermúdez-Pirela
1 reference
Clímaco Cano
1 reference
Mayerlim T Medina
1 reference
Aida Souki
1 reference
Miguel A Lemus
1 reference
Elliuz M Leal
1 reference
Hamid A Seyfi
1 reference
Raquel Cano
1 reference
Ana Ciscek
1 reference
Fernando Bermúdez-Arias
1 reference
Freddy Contreras
1 reference
Zafar H Israili
1 reference
Rafael Hernández-Hernández
1 reference
Manuel Valasco
1 reference
1 March 2007
1 reference
14
1 reference
2
1 reference
194-202
1 reference
Identifiers
1 reference